Prometheus and Rosetta Collaborate for Cancer Diagnostic Tests
Prometheus Laboratories Inc and Rosetta Genomics Ltd have announced the execution of a license and collaboration agreement under which Rosetta shall grant Prometheus US rights to three recently introduced, microRNA-based cancer diagnostic tests.
Read More